Table 2 Post-treatment (T1) descriptive statistics and zero-order correlations.

From: Moderators of inflammation-related depression: a prospective study of breast cancer survivors

Variable

M

SD

1

2

3

4

5

6

7

8

9

1. Depressive symptoms (BDI-II)

8.69

6.92

         

2. State anxiety (SAI)

35.00

8.47

0.74**

        

3. Perceived stress (PSS)

13.96

6.75

0.71**

0.74**

       

4. Negative affect (PANAS)

16.28

5.86

0.71**

0.75**

0.71**

      

5. Sleep disturbance (PSQI)

7.54

3.49

0.47**

0.31**

0.36**

0.33**

     

6. Childhood adversity (RF)a

27.83

10.44

0.27**

0.26**

0.23**

0.23**

0.05

    

7. Composite inflammatory index

0.53

2.22

0.16

0.13

0.08

0.01

0.14

0.19*

   

8. CRP (mg/L)

2.14

2.83

0.07

0.07

0.06

−0.05

0.12

−0.00

0.59**

  

9. IL-6 (pg/mL)

1.65

1.03

0.09

0.10

0.05

0.05

0.12

0.10

0.71**

0.46**

 

10. sTNF-RII (pg/mL)

2289.01

623.57

0.07

0.04

−0.01

−0.07

0.02

0.15

0.66**

0.08

0.18*

  1. Note. M = mean; SD = standard deviation; *p < .05; **p < .01. BDI-II Beck Depression Inventory II; SAI State Anxiety Questionnaire; PSS Perceived Stress Scale; PANAS Positive Affect Negative Affect Scale; PSQI Pittsburg Sleep Quality Inventory; RF Risky Families questionnaire; CRP C-reactive Protein; IL-6 Interleukin 6; sTNF-RII soluble tumor necrosis factor receptor type II.
  2. a All variables listed in this table were collected at T1, with the exception of the Risky Families questionnaire which was collected at T3.